Chung-liang Li
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.
Journal: Journal of breast cancer
Published: April 09, 2026
Development of a Nomogram-Based Clinical Estimation Model for Pathological Upstaging in Patients With Preoperative Ductal Carcinoma In Situ.
Journal: The Kaohsiung journal of medical sciences
Published: March 05, 2026
Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer.
Journal: Breast cancer (Dove Medical Press)
Published: February 01, 2026
Melatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancer.
Journal: International journal of medical sciences
Published: November 01, 2025
Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer.
Journal: Cancer genomics & proteomics
Published: September 04, 2025
Longitudinal multiomics analysis of endocrine therapy effects and gut microbiota in breast cancer recurrence.
Journal: Communications medicine
Published: February 11, 2025
Intraoperative radiation therapy (IORT) in Taiwanese breast cancer patients: factors influencing local relapse risk and disease-free survival.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: December 13, 2024
Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis.
Journal: International journal of molecular sciences
Published: December 21, 2023
Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case-control study.
Journal: Breast cancer research and treatment
Published: September 30, 2022
Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer.
Journal: International journal of molecular sciences
Published: August 26, 2022
De-glycosylated membrane PD-L1 in tumor tissues as a biomarker for responsiveness to atezolizumab (Tecentriq) in advanced breast cancer patients.
Journal: American journal of cancer research
Published: November 24, 2021
Correction: Pan et al. Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer. Cancers 2020, 12, 94.
Journal: Cancers
Published: August 26, 2021
Last Updated: 09/26/2026